- Home
- What We Do
- Investment Banking
- Transactions
Transactions
Our corporate finance solutions are tailored to our clients’ strategic goals and delivered based on in depth expertise across a wide range of sectors globally. We have a strong track record, participating in 187 transactions and raising C$19.5 Billion on behalf of our clients in Q3/20211.2.

US$75m
February 2021
Sundial Growers, Inc.
Sole Bookrunner (Follow-on)
CANNABIS
HEALTHCARE
EQUITY CAPITAL MARKETS
CANADA

C$130m
January 2021
Columbia Care
Lead Bookrunner (Bought Deal)
CANNABIS
HEALTHCARE
EQUITY CAPITAL MARKETS
US

US$275m
January 2021
Curaleaf
Lead Bookrunner (Overnight Marketed)
CANNABIS
HEALTHCARE
EQUITY CAPITAL MARKETS
US

C$40m
January 2021
Jushi
Lead Bookrunner (Overnight Marketed)
CANNABIS
HEALTHCARE
EQUITY CAPITAL MARKETS
US
CANADA

US$620m
January 2021
Subversive Capital Acquisition Corp.
Qualifying Transaction
CANNABIS
SPACS
EQUITY CAPITAL MARKETS
CANADA
Choice Consolidation Corp.
US$100m
January 2021
Choice Consolidation Corp.
Lead Bookrunner (IPO)
SPACS
CANNABIS
CANADA
Schultze Special Purpose Acq. Corp.
US$205m
December 2020
Schultze Special Purpose Acq. Corp.
Qualifying Transaction

EQUITY CAPITAL MARKETS
CANNABIS
SPACS
CANADA

US$30m
October 2020
Dosist
Financial Advisor (Private Placement)
HEALTHCARE
CANNABIS
EQUITY CAPITAL MARKETS
US
View transaction detail

C$116m
September 2020
Trulieve
Sole Lead (Equity Financing)
HEALTHCARE
CANNABIS
EQUITY CAPITAL MARKETS
US

September 2020
Trulieve
Financial Advisor on Acquisition of Pure Penn

HEALTHCARE
CANNABIS
M&A ADVISORY
US

September 2020
Trulieve
Financial Advisor on Acquisition of Solevo

HEALTHCARE
CANNABIS
M&A ADVISORY
US
CANADA

C$6m
September 2020
Flower One
Sole Lead (Equity Financing)
HEALTHCARE
CANNABIS
EQUITY CAPITAL MARKETS
CANADA